Drug Profile
Nortriptyline/prednisolone
Alternative Names: CRx-170; Prednisolone/nortriptyline - CombinatoRxLatest Information Update: 01 Aug 2016
Price :
$50
*
At a glance
- Originator CombinatoRx
- Developer Zalicus
- Class Anti-inflammatories; Dibenzocycloheptenes; Glucocorticoids; Non-opioid analgesics; Pregnadienetriols; Tricyclic antidepressants
- Mechanism of Action Catecholamine receptor modulators; Glucocorticoid receptor agonists; Steroid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Allergic asthma; Pain
Most Recent Events
- 25 Jul 2016 EPIRUS Biopharmaceuticals files for Chapter 7 bankruptcy (Epirus Biopharmaceuticals 8-K, July 2016)
- 17 Jul 2014 Zalicus has merged with EPIRUS Biopharmaceuticals
- 17 Jul 2014 Discontinued - Phase-II for Allergic asthma in United Kingdom (PO)